Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pramipexole
Drug ID BADD_D01817
Description Pramipexole is a drug used to treat the symptoms of Parkinson's Disease (PD). It is a _non-ergot dopamine agonist_ drug that is efficacious in treating various Parkinson's symptoms such as tremor, rigidity, and bradykinesia (slow movement) [A176867]. It was first approved by the FDA in 1997 [L5882]. Parkinson's Disease is one of the most common neurodegenerative disorders and causes a high level of disability in patients [A176855], leading to increased difficulty in performing activities of daily living due to symptoms that progress over time [A176858]. The prevalence of Parkinson's Disease worldwide has increased from approximately 2.5 million in 1990 to about 6.1 million in 2016 [A176861]. This increase may be attributed to an aging population along with other contributing factors [A176861]. In addition to the above FDA approval for Parkinson's Disease, pramipexole was also approved by the FDA in 2006 for the treatment of Restless Legs Syndrome (RLS) [A176873]. RLS is a sleep-related disorder characterized by unpleasant sensations in the lower extremities, often accompanied by an uncontrollable urge to move the legs [A176876].
Indications and Usage For the treatment of signs and symptoms of idiopathic Parkinson's disease
Marketing Status Prescription; Discontinued
ATC Code N04BC05
DrugBank ID DB00413
KEGG ID D05575
MeSH ID D000077487
PubChem ID 119570
TTD Drug ID D0G8NN
NDC Product Code 10370-253; 31722-908; 10370-306; 31722-906; 31722-910; 31722-911; 10370-251; 10370-252; 31722-909; 10370-305; 31722-907; 10370-254
Synonyms Pramipexole | 4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine | Pramipexol | 2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole | Dexpramipexole | Pramipexol, (R)-isomer | Mirapex | Pramipexol Dihydrobromide, (+-)-isomer | Pramipexol Dihydrochloride, (S)-isomer | Pramipexole Dihydrochloride Anhydrous | Sifrol | SND 919CL2x | SND919CL2x | SND-919CL2x | SND-919 | SND 919 | KNS 760704 | KNS760704 | KNS-760704 | Pramipexol, (+-)-isomer | Pramipexole Dihydrochloride | Pramipexole Hydrochloride Monohydrate | 2-Amino-6-propylaminotetrahydrobenzothiazole | 2 Amino 6 propylaminotetrahydrobenzothiazole | 6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
Chemical Information
Molecular Formula C10H17N3S
CAS Registry Number 104632-26-0
SMILES CCCNC1CCC2=C(C1)SC(=N2)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Bulimia nervosaD(3) dopamine receptorP19020Not Available25610366
Early satietyD(3) dopamine receptorP19020Not Available25610366
Food cravingD(3) dopamine receptorP19020Not Available25610366
Impulse control disordersD(3) dopamine receptorP19020Not Available25610366
Impulse-control disorderD(3) dopamine receptorP19020Not Available25610366
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Chromaturia20.02.01.002--
Chronic hepatitis11.07.01.009; 09.01.07.0210.001459%Not Available
Chronic lymphocytic leukaemia01.10.06.001; 16.01.06.001--Not Available
Chronic obstructive pulmonary disease22.03.01.007--Not Available
Circulatory collapse24.06.02.001--Not Available
Cold sweat23.02.03.002; 08.01.03.024--Not Available
Colitis07.08.01.001--
Colitis ulcerative10.02.01.004; 07.08.01.005--Not Available
Colon cancer16.13.01.001; 07.21.01.001--Not Available
Coma17.02.09.001--Not Available
Completed suicide19.12.01.001; 08.04.01.0100.000381%Not Available
Confusional state19.13.01.001; 17.02.03.0050.004378%
Conjunctivitis06.04.01.002; 11.01.06.012--
Constipation07.02.02.001--
Coordination abnormal17.02.02.0040.000730%Not Available
Coronary artery occlusion24.04.04.013; 02.02.01.006--Not Available
Cough22.02.03.001--
Crying19.04.02.002; 17.02.05.013; 12.02.11.001; 08.01.03.0050.002919%Not Available
Cyanosis22.02.02.007; 02.01.02.002; 24.03.01.007--
Cystitis20.03.02.002; 11.01.14.001--
Deafness04.02.01.001--Not Available
Death08.04.01.001--
Dehydration14.05.05.001--
Delirium19.13.02.0010.001824%
Delusion19.10.01.0010.002554%
Dementia19.20.02.001; 17.03.01.0010.000730%Not Available
Dental caries07.09.01.001--
Dependence19.07.02.0030.003649%Not Available
Depressed level of consciousness17.02.04.0020.000190%
Depressed mood19.15.02.0010.001459%Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 22 Pages